Immunization against influenza A virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system

This publication has 35 references indexed in Scilit:

• Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003
  Journal of Medical Virology, 2004
• Cross‐Reactive H1N1 Antibody Responses to a Live Attenuated Influenza Vaccine in Children: Implication for Selection of Vaccine Strains
  The Journal of Infectious Diseases, 2003
• Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants
  Vaccine, 1995
• Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans
  Vaccine, 1995
• Preparation and characterization of a purified influenza virus neuraminidase vaccine
  Vaccine, 1995
• Comparative Long-Term Effects in a Mouse Model System of Influenza Whole Virus and Purified Neuraminidase Vaccines Followed by Sequential Infections
  The Journal of Infectious Diseases, 1990
• Influenza: viral determinants of the pathogenicity and epidemicity of an invariant disease of variable occurrence
  Philosophical Transactions of the Royal Society of London. B, Biological Sciences, 1980
• Neuraminidase Content of Influenza Vaccines and Neuraminidase Antibody Responses after Vaccination of Immunologically Primed and Unprimed Populations
  The Journal of Infectious Diseases, 1977
• A Controlled Double-Blind Comparison of Reactogenicity, Immunogenicity, and Protective Efficacy of Whole-Virus and Split-Product Influenza Vaccines in Children
  The Journal of Infectious Diseases, 1977
• Correlated Studies of a Recombinant Influenza-Virus Vaccine. III. Protection against Experimental Influenza in Man
  The Journal of Infectious Diseases, 1971